Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments

Arthritis and Rheumatism

Volumn 40, Issue 11, 1997, Pages 1976-1983

  Rider, Lisa G ^a,m   Feldman, Brian M ^b   Perez, Maria D ^c   Rennebohm, Robert M ^d   Lindsley, Carol B ^e   Zemel, Lawrence S ^f   Wallace, Carol A ^g   Ballinger, Susan H ^h   Bowyer, Suzanne L ^h   Reed, Ann M ⁱ   Passo, Murray H ^j   Katona, Ildy M ^k   Miller, Frederick W ^a   Lachenbruch, Peter A ^l  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF KANSAS   (United States)

^f UNIVERSITY OF CONNECTICUT   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

^k UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^l CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^m CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE ACTIVITY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MYOPATHY; PEDIATRICS; PRIORITY JOURNAL; RELIABILITY; RHEUMATOLOGY; STATISTICAL ANALYSIS;

ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; HUMANS; OBSERVER VARIATION; PAIN MEASUREMENT; PARENTS; PATIENTS; PHYSICIANS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 15644378247     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401109     Document Type: Article

References (42)

1. Pachman LM: Polymyositis and dermatomyositis in children. In, Oxford Textbook of Rheumatology. Edited by PJ Maddison, DA Isenberg, P Woo, DN Glass. Oxford, Oxford University Press, 1993
2. Pachman LM: Juvenile dermatomyositis: pathophysiology and disease expression. Pediatr Clin North Am 42:1071-1098, 1995
3. Rider LG, Miller FW: New perspectives on the idiopathic inflammatory myopathies of childhood. Curr Opin Rheumatol 6:575-582, 1994
4. Feldman BM, Ayling-Campos A, Luy L, Stevens D, Silverman ED, Laxer RM: Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 22:326-331, 1995
5. Symmons DPM: Disease assessment indices: activity, damage, and severity. Baillieres Clin Rheumatol 9:267-285, 1995
6. Resnick JS, Mammel M, Mundale MO, Kottke FJ: Muscle strength as an index of response to therapy in childhood dermatomyositis. Arch Phys Med Rehabil 62:12-19, 1981
7. Miller LC, Michael AF, Baxter TL, Kim Y: Quantitative muscle testing in childhood dermatomyositis. Arch Phys Med Rehabil 69:610-613, 1988
8. Rider LG: Assessment of disease activity and its sequelae in children and adults with myositis. Curr Opin Rheumatol 8:495-506, 1996
9. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727-735, 1995
10. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202-1209, 1997
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630-640, 1992
12. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 39:363-369, 1996
13. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS, Adu D: Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371-380, 1997
14. Boers M, van Riel PL, Felson DT, Tugwell P: Assessing the activity of rheumatoid arthritis. Baillieres Clin Rheumatol 9:305-317, 1995
15. Anderson JJ, Felson DT, Meenan RF, Williams HJ: Which traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 32:1093-1099, 1989
16. Buchbinder R, Bombardier C, Yeung M, Tugwell P: Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 38:1568-1580, 1995
17. Anderson JJ, Chernoff MC: Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. J Rheumatol 20:535-537, 1993
18. Hassell AB, Davis MJ, Fowler PD, Clarke S, Fisher J, Shadforth MR, Jones PW, Dawes PT: The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. QJM 86:601-607, 1993
19. Bellamy N: Musculoskeletal Clinical Metrology. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1993
20. Ohnhaus EE, Adler R: Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain 1:379-384, 1975
21. Scott J, Huskisson EC: Graphic representation of pain. Pain 2:175-184, 1976
22. Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA: Studies with pain rating scales. Ann Rheum Dis 37:378-381, 1978
23. Bohan A, Peter JB, Bowman RL, Pearson CM: Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56:255-286, 1977
24. Cohen J: Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70:213-220, 1968
25. Liang MH, Fossel AH, Larson MG: Comparisons of five health status instruments for orthopedic evaluation. Med Care 28:632-642, 1990
26. Giannini EH, Lovell DJ, for the Pediatric Rheumatology Collaborative Study Group: Inter-physician reliability estimates for conventional disease activity measures in JRA (abstract). Arthritis Rheum 37 (suppl 9):S328, 1994
27. Pope JE, Baron M, Bellamy N, Campbell J, Curette S, Chulmers I, Dales P, Hanly J, Kaminska EA, Lee P, Sibley J, Stevens A: Variability of skin scores and clinical measurements in scleroderma. J Rheumatol 22:1271-1276, 1995
28. Bowyer SL, Blane CE, Sullivan DB, Cassidy JT: Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 103:882-888, 1983
29. Crowe WE, Bove KE, Levinson JE, Hilton PK: Clinical and pathogenetic implications of histoputhology in childhood polydermatomyositis. Arthritis Rheum 25:126-139, 1982
30. Taieb A, Guichard C, Salamon R, Maleville J: Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases. Pediatr Dermatol 2:275-281, 1985
31. Miller FW: Classification and prognosis of inflammatory muscle disease. Rheum Dis Clin North Am 20:811-826, 1994
32. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N: Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Semin Arthritis Rheum 23:34-46, 1993
33. Clarke AE, Bloch DA, Medsger TA Jr, Oddis CV: A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 38:1218-1224, 1995
34. Hanly JG, Mosher D, Sutton E, Weerasinghe S, Theriault D: Self-assessment of disease activity by patients with rheumatoid arthritis. J Rheumatol 23:1531-1538, 1996
35. Liang MH, Socher SA, Larson MG, Schur PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 32:1107-1118, 1989
36. Duffy CM, Arsenault L, Duffy KN: Level of agreement between parents and children in rating dysfunction in juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 20:2134-2139, 1993
37. Doherty E, Yanni G, Conroy RM, Bresnihan B: A comparison of child and parent ratings of disability and pain in juvenile chronic arthritis. J Rheumatol 20:1563-1566, 1993
38. Singh G, Athreya BH, Fries JF, Goldsmith DP: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 37:1761-1769, 1994
39. Wright FV, Kimber JL, Law M, Goldsmith CH, Crombie V, Dent P: The Juvenile Arthritis Functional Status Index (JASI): a validation study. J Rheumatol 23:1066-1079, 1996
40. Young NL, Yoshida KK, Williams JI, Bombardier C, Wright JG: The role of children in reporting their physical disability. Arch Phys Med Rehabil 76:913-918, 1995
41. Vandvik IH, Hoyeraal HM, Larsen S: Agreement between parents and physicians regarding clinical evaluation of patients with juvenile rheumatoid arthritis. Scand J Rheumatol 17:459-463, 1988
42. Ruperto N, Giannini EH: Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. Ann Rheum Dis 55:73-75, 1996